Piramal Pharma Share Price(PPLPHARMA)
Check the latest share price of Piramal Pharma, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 16 May 2025
NSE
🔔 Profit Growth Alert
Goldman Sachs highlights Piramal Pharma's strong profit growth potential, with a net profit increase of 51.6% in Q4, reaching Rs 153 crore.
Piramal Pharma Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹204.44Day's Price Range₹210.552 Week's Low
52 Week's High
₹136.152-Week Price Range₹307.9
| Returns % | |
| 1 Month Return | -5.96 % |
| 3 Month Return | + 4.37 % |
| 1 Year Return | + 39.87 % |
| 3 Year Return | + 9.79 % |
| 5 Year Return | + 9.79 % |
| Market Stats | |
| Previous Close | ₹208.61 |
| Open | ₹210.00 |
| Volume | 71.84L |
| Upper Circuit | ₹250.33 |
| Lower Circuit | ₹166.88 |
Piramal Pharma Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹27,656.43 Cr
Return on Equity (ROE)
6.53
PE Ratio (TTM)
302.33
Return on capital employed (ROCE)
8.27
Industry PE ratio
54.98
Beta (LTM)
0.75
P/B Ratio
2.54
Dividend Yield
0.09
PEG Ratio
495.16
Quarterly Earnings Growth YOY
51.57
EPS (TTM)
0.13
Sector
Pharmaceuticals
Book Value
59.8
Technical Analysis
Bearish
View Technical Analysis
How to invest in Piramal Pharma?
Investing in Piramal Pharma is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Piramal Pharma or PPLPHARMA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Piramal Pharma or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Piramal Pharma with just a few clicks!
Piramal Pharma Stock's Interest Amongst Investors
Piramal Pharma Valuation
Track how the P/E of Piramal Pharma has moved over time to understand valuation trends.
Piramal Pharma in the last 5 years
Lowest (-516.41x)
January 5, 2024
Industry (54.98x)
May 15, 2025
Today (302.33x)
May 15, 2025
Highest (2011.42x)
June 25, 2024
Today’s Price to Earnings Ratio: 302.33x
Analysts Recommendation on Piramal Pharma
Get updated buy, sell, and hold recommendations by analysts on Piramal Pharma.
based on 10 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Piramal Pharma. Average target price of ₹296
Source: S&P Global Market Intelligence
Analysts Forecast on Piramal Pharma
Get share price movements and forecasts by analysts on Piramal Pharma.
Piramal Pharma price forecast by 10 analysts
Upside of41.89%
High
₹340
Target
₹296.00
Low
₹255
Piramal Pharma target price ₹296, a slight upside of 41.89% compared to current price of ₹204.87. According to 10 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Piramal Pharma revenue growth forecast
Expected growth rate Q1, FY2027:48.22%
Forecast
Actual
Including amortisation and stock based compensations
Piramal Pharma EPS growth forecast
EPS estimate Q1, FY2027:4515.38%
Forecast
Actual
Source: S&P Global Market Intelligence
Piramal Pharma Financials
Get the annual and quarterly financial summary of Piramal Pharma, including revenue, profit, loss and more.
Piramal Pharma Index Inclusions
Piramal Pharma Earnings and Dividends
View detailed summary of the earnings and dividend history of Piramal Pharma.
Piramal Pharma Ltd Earnings Results
Piramal Pharma Ltd’s net profit jumped 51.57% since last year same period to ₹153.50Cr in the Q4 2024-2025. On a quarterly growth basis, Piramal Pharma Ltd has generated 4071.2% jump in its net profits since last 3-months.
Read More about Earnings ResultsPiramal Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Piramal Pharma Ltd has declared dividend of ₹0.11 - translating a dividend yield of 0.05%.
Read More about Dividends
Piramal Pharma Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Piramal Pharma.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 34.95% | 0.00 | |
| Foreign Institutions | 13.49% | 0.00 | |
| Mutual Funds | 12.73% | 0.00 | |
| Retail Investors | 18.44% | 0.00 | |
| Others | 20.4% | 0.00 |
Piramal Pharma vs Peers
Compare market cap, revenue, PE, and other key metrics of Piramal Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 27,656.43 | 1.96% | 0.58 | 17 | 8,171 | |
| BUY | 26,938.06 | 117.56% | 0.52 | 300 | 1,051 | |
| BUY | 14,426.21 | 26.51% | 0.57 | 72 | 6,702 | |
| NA | 4,918.77 | 4.12% | 0.79 | -388 | 75 | |
| BUY | 14,087.25 | 41.63% | 0.68 | 218 | 1,296 |
Piramal Pharma News & Key Events
Latest news and events at one place to help you take investing decisions in Piramal Pharma.
Piramal Pharma Reports Strong Q4 but Faces Growth Challenges - 15 May, 2025
Piramal Pharma's Q4 results show a 52% profit increase, but the company anticipates muted growth in FY26 due to uncertainties. Stock fell 5% post-results.Piramal Pharma Reports Strong Financial Growth - 14 May, 2025
Piramal Pharma's consolidated net sales for March 2025 reached Rs 2,754.07 crore, a 7.9% increase year-over-year. Net profit surged 51.57% to Rs 153.50 crore.Piramal Pharma Invests $90 Million in US - 13 May, 2025
Piramal Pharma Ltd shares increased by 2.81% following the announcement of a $90 million investment to expand its manufacturing facilities in the U.S., enhancing production capabilities and aligning with growing demand.Piramal Pharma Receives USFDA EIR - 12 May, 2025
Piramal Pharma's stock rose 2.14% after receiving an Establishment Inspection Report (EIR) from the USFDA for its Turbhe facility, indicating successful closure of a GMP inspection. Despite this positive news, the company reported a 63.6% drop in net profit for Q3 FY25.Piramal Healthcare Enters Major Subscription Agreement - 23 Apr, 2025
Piramal Healthcare Inc. has signed a Stock Subscription Agreement to acquire 1,903 optionally convertible redeemable preference shares for USD 190.3 million, with part of the payment adjusted against an existing loan. The transaction is expected to complete in six months and does not require regulatory approval.
Insights on Piramal Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 3.68 Cr → 153.5 Cr (in ₹), with an average increase of 97.6% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 11.66% to 12.73% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.23K Cr → 2.81K Cr (in ₹), with an average increase of 20.6% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 58.1% return, outperforming this stock by 18.2%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 34.95% of holdings in Mar 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 13.68% to 13.49% in Mar 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 18.87% to 18.44% in Mar 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, PPLPHARMA stock has moved down by -6.0%
About Piramal Pharma
Revenue: ₹2,754.07Cr as on March 2025 (Q1 25)
Net Profit: ₹153.50Cr as on March 2025 (Q1 25)
Listing date: 19 Oct, 2022
Chairperson Name: Nandini Piramal
| Organisation | Piramal Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Nandini Piramal |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Piramal Pharma
Check out the Mutual Funds with significant holdings in Piramal Pharma.
FAQs
What is Piramal Pharma Ltd price today?
Piramal Pharma Ltd share price today stands at ₹204.87, Open: ₹210, Previous Close: ₹208.61, High: ₹210.5, Low: ₹204.44, 52 Week High: ₹307.9, 52 Week Low: ₹136.1.
How to Buy Piramal Pharma Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Piramal Pharma Ltd shares
What are today's traded volumes of Piramal Pharma Ltd?
Today's traded volume of Piramal Pharma Ltd(PPLPHARMA) is 71.84L.
What is today's market capitalisation of Piramal Pharma Ltd?
Today's market capitalisation of Piramal Pharma Ltd(PPLPHARMA) is ₹27,656.43 Cr.
What is the 52 Week High and Low Range of Piramal Pharma Ltd?
How much percentage Piramal Pharma Ltd is down from its 52 Week High?
Piramal Pharma Ltd (PPLPHARMA) share price is ₹204.87. It is down -33.46% from its 52 Week High price of ₹307.9
How much percentage Piramal Pharma Ltd is up from its 52 Week low?
Piramal Pharma Ltd (PPLPHARMA) share price is ₹204.87. It is up 50.53% from its 52 Week Low price of ₹136.1